Patents by Inventor Claudia Yvonne Janda

Claudia Yvonne Janda has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • WNT surrogate molecules and uses thereof
    Patent number: 11773171
    Abstract: The present invention provides Wnt pathway agonists and related compositions, which may be used in any of a variety of therapeutic methods for the treatment of diseases.
    Type: Grant
    Filed: December 19, 2018
    Date of Patent: October 3, 2023
    Assignee: Surrozen Operating, Inc.
    Inventors: Yang Li, Tom Zhiye Yuan, Aaron Ken Sato, Wen-Chen Yeh, Claudia Yvonne Janda, Tristan William Fowler, Helene Baribault, Kuo-Pao Lai, Liqin Xie, Randall J. Brezski, Chenggang Lu
  • WNT SIGNALING AGONIST MOLECULES
    Publication number: 20230183359
    Abstract: Wnt signaling agonist compositions and methods for their use are provided. Wnt signaling agonists of the invention comprise a frizzled binding moiety, which is fused or conjugated to an LRP5 or LRP6 binding moiety and to an R-spondin agonist.
    Type: Application
    Filed: November 22, 2022
    Publication date: June 15, 2023
    Inventors: Kenan Christopher Garcia, Claudia Yvonne Janda
  • WNT SIGNALING AGONIST MOLECULES
    Publication number: 20210403578
    Abstract: Wnt signaling agonist compositions and methods for their use are provided. Wnt signaling agonists of the invention comprise a frizzled binding moiety, which is fused or conjugated to an LRP5 or LRP6 binding moiety.
    Type: Application
    Filed: September 8, 2021
    Publication date: December 30, 2021
    Inventors: Kenan Christopher Garcia, David Baker, Claudia Yvonne Janda, Luke Dang, James Daniel Moody
  • WNT signaling agonist molecules
    Patent number: 11142577
    Abstract: Wnt signaling agonist compositions and methods for their use are provided. Wnt signaling agonists of the invention comprise a frizzled binding moiety, which is fused or conjugated to an LRP5 or LRP6 binding moiety.
    Type: Grant
    Filed: September 11, 2015
    Date of Patent: October 12, 2021
    Assignees: The Board of Trustees of the Leland Stanford Junior University, University of Washington
    Inventors: Kenan Christopher Garcia, David Baker, Claudia Yvonne Janda, Luke Dang, James Daniel Moody
  • ANTI-FRIZZLED ANTIBODIES AND METHODS OF USE
    Publication number: 20210087280
    Abstract: The present invention provides anti-Fzd monoclonal antibodies and related compositions, which may be used in any of a variety of therapeutic methods for the treatment of diseases.
    Type: Application
    Filed: December 19, 2018
    Publication date: March 25, 2021
    Inventors: Yang LI, Tom Zhiye YUAN, Aaron Ken SATO, Wen-Chen YEH, Chenggang LU, Parthasarathy SAMPATHKUMAR, Claudia Yvonne JANDA
  • WNT SURROGATE MOLECULES AND USES THEREOF
    Publication number: 20200308287
    Abstract: The present invention provides Wnt pathway agonists and related compositions, which may be used in any of a variety of therapeutic methods for the treatment of diseases.
    Type: Application
    Filed: December 19, 2018
    Publication date: October 1, 2020
    Inventors: Yang LI, Tom Zhiye YUAN, Aaron Ken SATO, Wen-Chen YEH, Claudia Yvonne JANDA, Tristan William FOWLER, Helene BARIBAULT, Kuo-Pao LAI, Liqin XIE, Randall J. BREZSKI, Chenggang LU
  • WNT SIGNALING AGONIST MOLECULES
    Publication number: 20200199237
    Abstract: Wnt signaling agonist compositions and methods for their use are provided. Wnt signaling agonists of the invention comprise a frizzled binding moiety, which is fused or conjugated to an LRP5 or LRP6 binding moiety and to an R-spondin agonist.
    Type: Application
    Filed: March 5, 2020
    Publication date: June 25, 2020
    Inventors: Kenan Christopher Garcia, Claudia Yvonne Janda
  • WNT SIGNALING AGONIST MOLECULES
    Publication number: 20200199238
    Abstract: Wnt signaling agonist compositions and methods for their use are provided. Wnt signaling agonists of the invention comprise a frizzled binding moiety, which is fused or conjugated to an LRP5 or LRP6 binding moiety and to an R-spondin agonist.
    Type: Application
    Filed: March 5, 2020
    Publication date: June 25, 2020
    Inventors: Kenan Christopher Garcia, Claudia Yvonne Janda
  • WNT SIGNALING AGONIST MOLECULES
    Publication number: 20170349659
    Abstract: Wnt signaling agonist compositions and methods for their use are provided. Wnt signaling agonists of the invention comprise a frizzled binding moiety, which is fused or conjugated to an LRP5 or LRP6 binding moiety and to an R-spondin agonist.
    Type: Application
    Filed: June 2, 2017
    Publication date: December 7, 2017
    Inventors: Kenan Christopher Garcia, Claudia Yvonne Janda
  • WNT SIGNALING AGONIST MOLECULES
    Publication number: 20170306029
    Abstract: Wnt signaling agonist compositions and methods for their use are provided. Wnt signaling agonists of the invention comprise a frizzled binding moiety, which is fused or conjugated to an LRP5 or LRP6 binding moiety.
    Type: Application
    Filed: September 11, 2015
    Publication date: October 26, 2017
    Inventors: Kenan Christopher Garcia, David Baker, Claudia Yvonne Janda, Luke Dang, James Daniel Moody